Solara Active Pharma Sciences Ltd
Capital Structure and Liquidity Solara Active Pharma Sciences Ltd has a debt-to-equity ratio of 0.73, indicating a moderate level of leverage. The company's liquidity position is assessed as medium, with a current ratio of 0.77, suggesting that it may face challenges in meeting short-term obligations with its current assets. The company's free cash flow stands at 597.4 million INR, which is lower than its operating cash flow of 2,128.2 million INR, indicating that capital expenditures have consumed a significant portion of its operating cash flow. ### Profitability and Returns The company's profitability is modest, with a net income of 5.4 million INR and an operating income of 1,080.5 million INR. Its return on equity (ROE) is 0.05%, and return on assets (ROA) is 0.02%, both of which are below the industry median for pharmaceutical companies. These low returns suggest that the company is not effectively utilizing its equity and assets to generate profits. ### Segments and Geographic Exposure The company's revenue is concentrated in a single business segment, as disclosed in its financial statements. There is no detailed breakdown of geographic revenue distribution in the provided data, but the company's operations are primarily based in India, as indicated by the use of INR as the reporting currency. ### Growth Trajectory The company's revenue for the latest reporting period is 12,837.6 million INR. While the company has a positive free cash flow, the absence of historical revenue data makes it difficult to assess its growth trajectory. The analyst estimate for revenue is aligned with the reported figure, indicating that the company is meeting market expectations. ### Risk Factors The company faces a medium liquidity risk, as its current ratio is below 1, and it has a negative net cash position after accounting for total debt. The risk of dilution is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's capital structure includes a long-term debt of 7,960.8 million INR, which could pose a refinancing risk if interest rates rise. ### Recent Events The most recent financial data available is from the latest market data filing, which includes the company's revenue and profitability figures. There are no additional filings or transcripts provided that would indicate recent strategic changes or operational developments.
Business. (unavailable from LLM output)
Classification. (unavailable from LLM output)
- Solara Active Pharma Sciences Ltd has a moderate level of leverage with a debt-to-equity ratio of 0.73.
- The company's liquidity position is medium, with a current ratio of 0.77.
- Profitability is weak, with a net income of 5.4 million INR and low ROE and ROA.
- The company's revenue is concentrated in a single business segment, with no detailed geographic breakdown.
- The company has a positive free cash flow but faces potential liquidity challenges due to its current ratio and net cash position.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.